Open AccessPROBLEMS OF COMMERCIALIZATION OF INNOVATIONS IN MEDICAL INDUSTRY
Author(s) -
Daria Alekseevna Milkevich,
Mikhail Yakovlevich Veselovskiy
Publication year - 2019
Publication title -
vestnik astrahanskogo gosudarstvennogo tehničeskogo universiteta. seriâ: èkonomika
Language(s) - English
Resource type - Journals
eISSN - 2309-9798
pISSN - 2073-5537
DOI - 10.24143/2073-5537-2019-2-50-57
Subject(s) - commercialization , business , health care , population , russian federation , health technology , consistency (knowledge bases) , medical equipment , quality (philosophy) , industrial organization , economic growth , marketing , medicine , economic policy , economics , environmental health , philosophy , geometry , mathematics , nursing , epistemology
The article highlights the problems associated with improving quality, reducing costs and increasing availability of medical care with limited funding in Russia. The necessity to ensure a greater consistency of transformation of medical services into cost-effective products has been substantiated. The main engine of progress is innovations whose development and introduction into the medical industry can provide a new level of medical care for the population. It has been stated that at present in the Russian Federation there are no large industrial enterprises in the medical industry that are able to enter the world market with their innovative developments. Development of medicine requires the complex long-term research, clinical trials and significant financial and resource costs, which in most cases leads to unrealized implementation. Medical industry is one of the most high-tech industries characterized by a high level of research and innovations. The structure of production of medical products and equipment is considered. The stages of the innovation process (development of innovation and its commercialization) have been designated. The elements of the innovation system in health care have been shown. The factors constraining the innovative development of the medical industry in Russia, including insufficient state participation, are investigated. The comparative analysis of the current costs on health care in different countries has been carried out; Russia is found to rank 35th place among 44 countries under study. The state federal programs of the Russian Federation aimed at creating a national innovation system in the medical industry, changing the structure of spending on medicine and approaching the level of spending of developed countries have been considered. The problems of commercialization in the Russian medical industry, which lead to a slowdown in production growth, are formulated, and possible solutions are proposed.